104 related articles for article (PubMed ID: 7783062)
1. A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus.
Hackshaw KV; Shi Y; Brandwein SR; Jones K; Westcott JY
J Rheumatol; 1995 Mar; 22(3):462-8. PubMed ID: 7783062
[TBL] [Abstract][Full Text] [Related]
2. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
Grissom CK; Richer LD; Elstad MR
Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
[TBL] [Abstract][Full Text] [Related]
3. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.
Israel E; Rubin P; Kemp JP; Grossman J; Pierson W; Siegel SC; Tinkelman D; Murray JJ; Busse W; Segal AT; Fish J; Kaiser HB; Ledford D; Wenzel S; Rosenthal R; Cohn J; Lanni C; Pearlman H; Karahalios P; Drazen JM
Ann Intern Med; 1993 Dec; 119(11):1059-66. PubMed ID: 8239223
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.
Israel E; Cohn J; Dubé L; Drazen JM
JAMA; 1996 Mar; 275(12):931-6. PubMed ID: 8598621
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
Liu MC; Dubé LM; Lancaster J
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
[TBL] [Abstract][Full Text] [Related]
6. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
[TBL] [Abstract][Full Text] [Related]
7. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Helfgott S; Maier AL; Petrillo G; Henson B; Rubin P; Sperling R
J Rheumatol; 1992 Oct; 19(10):1537-41. PubMed ID: 1334515
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
Woodruff PG; Albert RK; Bailey WC; Casaburi R; Connett JE; Cooper JA; Criner GJ; Curtis JL; Dransfield MT; Han MK; Harnden SM; Kim V; Marchetti N; Martinez FJ; McEvoy CE; Niewoehner DE; Reilly JJ; Rice K; Scanlon PD; Scharf SM; Sciurba FC; Washko GR; Lazarus SC;
COPD; 2011 Feb; 8(1):21-9. PubMed ID: 21299475
[TBL] [Abstract][Full Text] [Related]
9. Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.
Mohebati A; Milne GL; Zhou XK; Duffield-Lillico AJ; Boyle JO; Knutson A; Bosworth BP; Kingsley PJ; Marnett LJ; Brown PH; Akpa EG; Szabo E; Dannenberg AJ
Cancer Prev Res (Phila); 2013 Jul; 6(7):646-55. PubMed ID: 23682075
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.
Kane GC; Pollice M; Kim CJ; Cohn J; Dworski RT; Murray JJ; Sheller JR; Fish JE; Peters SP
J Allergy Clin Immunol; 1996 Feb; 97(2):646-54. PubMed ID: 8621850
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.
Meltzer SS; Hasday JD; Cohn J; Bleecker ER
Am J Respir Crit Care Med; 1996 Mar; 153(3):931-5. PubMed ID: 8630575
[TBL] [Abstract][Full Text] [Related]
12. A pilot study examining the role of zileuton in atopic dermatitis.
Woodmansee DP; Simon RA
Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):548-52. PubMed ID: 10619348
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.
DuBuske LM; Grossman J; Dubé LM; Swanson LJ; Lancaster JF
Am J Manag Care; 1997 Apr; 3(4):633-40. PubMed ID: 10169531
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group.
Schwartz HJ; Petty T; Dubé LM; Swanson LJ; Lancaster JF
Arch Intern Med; 1998 Jan; 158(2):141-8. PubMed ID: 9448552
[TBL] [Abstract][Full Text] [Related]
15. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients.
Lehnigk B; Rabe KF; Dent G; Herst RS; Carpentier PJ; Magnussen H
Eur Respir J; 1998 Mar; 11(3):617-23. PubMed ID: 9596112
[TBL] [Abstract][Full Text] [Related]
16. Effects of 5-lipoxygenase inhibitor zileuton on airway responses to inhaled swine house dust in healthy subjects.
Larsson BM; Kumlin M; Sundblad BM; Larsson K; Dahlén SE; Palmberg L
Respir Med; 2006 Feb; 100(2):226-37. PubMed ID: 15939582
[TBL] [Abstract][Full Text] [Related]
17. Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.
Tardif JC; L'allier PL; Ibrahim R; Grégoire JC; Nozza A; Cossette M; Kouz S; Lavoie MA; Paquin J; Brotz TM; Taub R; Pressacco J
Circ Cardiovasc Imaging; 2010 May; 3(3):298-307. PubMed ID: 20190281
[TBL] [Abstract][Full Text] [Related]
18. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
[TBL] [Abstract][Full Text] [Related]
19. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
Chang DM; Lan JL; Lin HY; Luo SF
Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
